Heart in Diabetes (HiD)
Day 3
Heart in Diabetes (HiD)
FLOW - The First Dedicated CKD Outcomes Trial With a GLP-1 Receptor Agonist
FEATURING
Richard Pratley
- 2 views
- October 9, 2024
Heart in Diabetes (HiD)
Social Isolation, Loneliness, and Diabetes
FEATURING
Lu Qi
- 2 views
- October 7, 2024
Heart in Diabetes (HiD)
Impact of Cumulative Risk Factor Exposure on Incident Cardiovascular Disease
FEATURING
Michael J. Domanski
- 5 views
- October 7, 2024
Heart in Diabetes (HiD)
Gestational Diabetes and Future Cardiovascular Disease in Women
FEATURING
Kausik Ray
- 7 views
- October 7, 2024
Heart in Diabetes (HiD)
SELECT: GLP1 RA Impact on ASCVD in Obesity Without Diabetes
FEATURING
Donna Ryan
- 3 views
- October 7, 2024
Heart in Diabetes (HiD)
GLP1-RA and Risk of Stroke
FEATURING
Lawrance A. Leiter
- 3 views
- October 7, 2024
Heart in Diabetes (HiD)
Exercise in Diabetes Care - From CV Outcomes to Longevity
FEATURING
Jane Reusch
- 5 views
- October 7, 2024
Heart in Diabetes (HiD)
The Dynamic Duo: GLP-1 Receptor Agonists and SGLT2 Inhibitors
FEATURING
Robert S. Busch
- 5 views
- October 7, 2024
Heart in Diabetes (HiD)
Technology in the Management of Diabetes
FEATURING
George Grunberger
- 5 views
- October 7, 2024
Heart in Diabetes (HiD)
The Different Etiologies of Cardiomyopathy
FEATURING
Lee Goldberg
- 9 views
- October 7, 2024
Heart in Diabetes (HiD)
Predicting and Preventing Hospital Admissions in Patients With Heart Failure: It's Really Difficult
FEATURING
Mark T. Kearney
- 5 views
- October 7, 2024
Heart in Diabetes (HiD)
The Proper Management of a Patient With Heart Failure Circa 2024
FEATURING
Stephen Greene
- 9 views
- October 7, 2024